Insiders / Marks Gilbert Lynn

Marks Gilbert Lynn

CIK 1916940personinsider
Companies
1
First seen
Jan 14, 2026
Last activity
Mar 23, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
AN2 Therapeutics, Inc. · ANTXDirector75,30975,3098

All securities held

2 positions · latest reported per filing
CompanySecuritySharesAs of
AN2 Therapeutics, Inc.Common Stock75,309Jan 12, 2026
AN2 Therapeutics, Inc.Stock Option (Right to Buy)Derivative20,400Feb 20, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Jan 12, 2026GrantANTX
AN2 Therapeutics, Inc.
Common Stock
$0+12K
+18.13%
75,309
0.20% of shares
low
Mar 19, 2026OtherANTX
AN2 Therapeutics, Inc.
Stock Option (right to buy)
-24K
-100.00%
0
0.00% of shares
low
Mar 19, 2026GrantANTX
AN2 Therapeutics, Inc.
Stock Option (right to buy)
+24K
23,742
0.06% of shares
low
Mar 19, 2026OtherANTX
AN2 Therapeutics, Inc.
Stock Option (right to buy)
-10K
-100.00%
0
0.00% of shares
low
Mar 19, 2026GrantANTX
AN2 Therapeutics, Inc.
Stock Option (right to buy)
+10K
10,362
0.03% of shares
low
Mar 19, 2026OtherANTX
AN2 Therapeutics, Inc.
Stock Option (right to buy)
-11K
-100.00%
0
0.00% of shares
low
Mar 19, 2026GrantANTX
AN2 Therapeutics, Inc.
Stock Option (right to buy)
+11K
10,665
0.03% of shares
low
Feb 20, 2026GrantANTX
AN2 Therapeutics, Inc.
Stock Option (Right to Buy)
+20K
20,400
0.05% of shares
low